eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Approval Pathway for Biosimilar and Interchangeable Biological Products; Hearing

Approval Pathway for Biosimilar and Interchangeable Biological Products; Hearing

Document ID: FDA-2010-N-0477-0001
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2010-24853
View Document:  View as format pdf View as format html

Details Information

Document Subtype: NPH-Notice of Opportunity of Hearing
Received Date: October 05 2010, at 12:00 AM Eastern Daylight Time
Start-End Page: 61497 - 61501
Page Count: 5
Comment Start Date: October 5 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: December 31 2010, at 11:59 PM Eastern Standard Time

Comments

    View All
Total: 70
LG Life Sciences, Ltd. - Comment
Posted: 11/09/2010     ID: FDA-2010-N-0477-0003

Dec 31,2010 11:59 PM ET
Sobel Medical Associates, Ltd. - Comment
Posted: 11/09/2010     ID: FDA-2010-N-0477-0004

Dec 31,2010 11:59 PM ET
Consumers Union - Comment
Posted: 11/09/2010     ID: FDA-2010-N-0477-0009

Dec 31,2010 11:59 PM ET
NORTHEASTERN UNIVERSITY - Comment
Posted: 12/21/2010     ID: FDA-2010-N-0477-0013

Dec 31,2010 11:59 PM ET
TLG Consulting Inc. - Comment
Posted: 12/21/2010     ID: FDA-2010-N-0477-0014

Dec 31,2010 11:59 PM ET

Related Documents

Total: 0
No documents available.